Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$13.58 - $17.36 $129,661 - $165,753
-9,548 Reduced 1.82%
515,955 $8.12 Million
Q4 2023

Feb 13, 2024

BUY
$10.11 - $16.54 $50,620 - $82,815
5,007 Added 0.96%
525,503 $8.48 Million
Q3 2023

Nov 13, 2023

BUY
$12.46 - $15.48 $34,028 - $42,275
2,731 Added 0.53%
520,496 $6.62 Million
Q2 2023

Aug 11, 2023

BUY
$13.28 - $15.96 $160,608 - $193,020
12,094 Added 2.39%
517,765 $7.29 Million
Q1 2023

May 15, 2023

BUY
$14.26 - $22.1 $924,119 - $1.43 Million
64,805 Added 14.7%
505,671 $7.81 Million
Q4 2022

Feb 13, 2023

BUY
$14.85 - $19.04 $121,859 - $156,242
8,206 Added 1.9%
440,866 $7.23 Million
Q3 2022

Nov 14, 2022

SELL
$12.38 - $20.23 $10,102 - $16,507
-816 Reduced 0.19%
432,660 $8 Million
Q2 2022

Aug 12, 2022

BUY
$9.11 - $13.98 $295,610 - $453,637
32,449 Added 8.09%
433,476 $5.7 Million
Q1 2022

May 13, 2022

SELL
$6.87 - $11.11 $66,453 - $107,467
-9,673 Reduced 2.36%
401,027 $3.72 Million
Q4 2021

Feb 08, 2022

BUY
$7.7 - $37.13 $74,998 - $361,646
9,740 Added 2.43%
410,700 $4.01 Million
Q3 2021

Nov 15, 2021

SELL
$26.46 - $37.15 $618,608 - $868,529
-23,379 Reduced 5.51%
400,960 $13.6 Million
Q2 2021

Aug 13, 2021

SELL
$32.73 - $47.95 $486,105 - $712,153
-14,852 Reduced 3.38%
424,339 $15.5 Million
Q1 2021

May 12, 2021

SELL
$40.39 - $56.73 $686,953 - $964,863
-17,008 Reduced 3.73%
439,191 $19.7 Million
Q4 2020

Feb 11, 2021

SELL
$51.77 - $66.18 $84,385 - $107,873
-1,630 Reduced 0.36%
456,199 $26 Million
Q3 2020

Nov 16, 2020

BUY
$43.8 - $58.16 $418,684 - $555,951
9,559 Added 2.13%
457,829 $23.5 Million
Q2 2020

Aug 14, 2020

BUY
$37.05 - $65.03 $6.37 Million - $11.2 Million
171,828 Added 62.16%
448,270 $26.8 Million
Q1 2020

May 14, 2020

BUY
$33.63 - $69.4 $570,432 - $1.18 Million
16,962 Added 6.54%
276,442 $11.4 Million
Q4 2019

Feb 14, 2020

BUY
$31.7 - $69.93 $406,774 - $897,341
12,832 Added 5.2%
259,480 $16.2 Million
Q3 2019

Nov 13, 2019

BUY
$19.95 - $38.85 $2.47 Million - $4.82 Million
123,979 Added 101.07%
246,648 $8.37 Million
Q2 2019

Aug 13, 2019

SELL
$21.05 - $26.21 $253,021 - $315,044
-12,020 Reduced 8.92%
122,669 $2.77 Million
Q1 2019

May 13, 2019

SELL
$20.65 - $29.55 $88,898 - $127,212
-4,305 Reduced 3.1%
134,689 $3.13 Million
Q4 2018

Feb 12, 2019

SELL
$19.08 - $36.14 $22,418 - $42,464
-1,175 Reduced 0.84%
138,994 $2.92 Million
Q3 2018

Nov 14, 2018

BUY
$33.57 - $42.1 $850,764 - $1.07 Million
25,343 Added 22.07%
140,169 $5.43 Million
Q2 2018

Sep 18, 2018

BUY
$20.06 - $44.95 $285,674 - $640,132
14,241 Added 14.16%
114,826 $4.52 Million
Q2 2018

Aug 14, 2018

BUY
$20.06 - $44.95 $318,011 - $712,592
15,853 Added 18.71%
100,585 $3.96 Million
Q1 2018

May 09, 2018

BUY
$20.04 - $29.71 $193,185 - $286,404
9,640 Added 12.84%
84,732 $1.7 Million
Q4 2017

Feb 14, 2018

BUY
$16.54 - $24.2 $1.24 Million - $1.82 Million
75,092
75,092 $1.7 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.